Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04479007
Other study ID # NL61112.018.17
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 11, 2017
Est. completion date August 11, 2020

Study information

Verified date July 2020
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Kirsten Kalverda, MD
Phone +31205664356
Email k.a.kalverda@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute respiratory distress syndrome is a severe complication of critical illness. The diagnosis of ARDS is difficult, and it could be important to differentiate ARDS from other causes of acute respiratory failure. Innovative probe-based imaging techniques such as 'Confocal Laser Endomicroscopy' (CLE) and Optical Coherence Tomography (OCT) are high resolution optical techniques that, combined with conventional bronchoscopy, have been found to provide non-invasive, real-time near-histology information about the alveolar compartment in non ventilated non-critically ill patients.


Description:

It is important to identify the underlying cause of respiratory failure, in order to determine the appropriate treatment. Histopathology would help treatment decisions, however is in the fast majority of this critically ill patient-group not available. CLE is enables near histology/microscopic analysis during bronchoscopy, by tissue illumination with a low-power laser. Optical Coherence Tomography is the optical equivalent of B-mode ultrasonography, that consists of a small rotating optical fibre. Both the CLE and OCT techniques are minimally invasive and little time consuming. Therefore different areas of the lung can be sequentially imaged. With this pilot study the investigators aim to describe normal alveolar areas and areas with abnormalities in critically ill patients with non resolving acute respiratory failure mandating a standard bronchoscopy or laryngoscopy with or without bronchoalveolar lavage.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 11, 2020
Est. primary completion date August 11, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Admitted to intensive care unit of academic medical center in Amsterdam

- Indication for a procedure to investigate the airways that can be combined with pCLE/OCT

Exclusion Criteria:

- Inability and willingness to provide informed consent by family-members

- Inability to comply with the study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Probe based optical techniques
During the intervention of inspecting the airways, different segments of the alveolar compartment will be imaged by two different probe based (CLE and OCT).

Locations

Country Name City State
Netherlands Academisch Medisch Centrum Amsterdam Noord-Holland

Sponsors (1)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Technical feasibility of various (diseased/non-diseased on HRCT-scan) alveolar compartments in mechanically ventilated patients Percentage of successful imaging coss sectional (1 day)
Secondary Comparison of pCLE/OCT to radiological patterns Degree of similarity pCLE/OCT-imaging compared to HRCT cross sectional (1 day)
Secondary Comparison of pCLE/OCT with pathology Degree of similarity between pCLE/OCT characteristics with pathology (in case available) cross sectional (1 day)